Dr. Norkin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1301 Palm Ave
Jacksonville, FL 32207Phone+1 904-202-7300
Education & Training
Detroit Medical Center/Wayne State UniversityFellowship, Hematology and Medical Oncology, 2007 - 2010
St Vincent HospitalResidency, Internal Medicine, 2004 - 2007
Novosibirsk State Medical AcademyClass of 1998
Certifications & Licensure
FL State Medical License 2010 - 2026
MI State Medical License 2007 - 2010- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia Start of enrollment: 2011 Oct 01
- Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia Start of enrollment: 2012 Dec 13
- HLA-Mismatched Unrelated Donor Bone Marrow Transplantation With Post-Transplantation Cyclophosphamide Start of enrollment: 2016 Dec 01
Publications & Presentations
PubMed
- 18 citationsThree-Year Outcomes in Recipients of Mismatched Unrelated Bone Marrow Donor Transplants Using Post-Transplantation Cyclophosphamide: Follow-Up from a National Marrow D...Bronwen E Shaw, Antonio Martin Jimenez-Jimenez, Linda J Burns, Brent R Logan, Farhad Khimani
Transplantation and Cellular Therapy. 2023-03-01 - 21 citationsAbatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.Muna Qayed, Ben Watkins, Scott Gillespie, Brandi Bratrude, Kayla Betz
Blood Advances. 2021-11-09 - 91 citationsNational Marrow Donor Program-Sponsored Multicenter, Phase II Trial of HLA-Mismatched Unrelated Donor Bone Marrow Transplantation Using Post-Transplant CyclophosphamideBronwen E. Shaw, Antonio Jimenez-Jimenez, Linda J. Burns, Brent R. Logan, Farhad Khimani
Journal of Clinical Oncology. 2021-04-27
Other Languages
- Russian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
